140410.KQ
Mezzion Pharma Co.,Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 65,000.00
−1.66%Year over year
Reported trailing growth
- Revenue
- +6.9%
- EBITDA
- -16.1%
- EBIT
- -9.4%
- EPS
- -16.4%
- Free cash flow
- +2.4%
- Operating cash flow
- -92.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -36.4%
- EBITDA
- -18.9%
- EBIT
- -17.3%
- Net income
- -79.3%
- EPS
- -75.6%
- Free cash flow
- +47.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026